首页 | 本学科首页   官方微博 | 高级检索  
     

替罗非班对急性心肌梗死患者经皮冠状动脉介入治疗术后抗炎、促炎因子的影响
引用本文:潘国洲. 替罗非班对急性心肌梗死患者经皮冠状动脉介入治疗术后抗炎、促炎因子的影响[J]. 中国医药导报, 2011, 8(29): 57-58,60
作者姓名:潘国洲
作者单位:广西壮族自治区百色市人民医院心内科,广西百色,533000
摘    要:目的:研究急性心肌梗死(AMI)患者经皮冠状动脉介入治疗(PCI)术后应用替罗非班对抗炎因子和促炎因子的影响。方法:选择2009年10月~2010年12月我院行PCI的急性心肌梗死患者95例,将其分为常规治疗组(n=54)和替罗非班组(n=41),两组分别测定术前1 h、术后24 h血清IL-6、IL-10、P-选择素和C反应蛋白(CRP)含量。结果:常规治疗组PCI术后仅IL-6降低(t=2.132,P=0.046),其他指标均未见明显变化。而替罗非班组术后IL-6(t=4.315,P=0)、CRP(t=2.970,P=0.005)和P-选择素(t=3.308,P=0.002)均较治疗前及常规治疗组显著下降;IL-10上升明显,差异有统计学意义(t=2.424,P=0.020)。结论:替罗非班可抑制血小板聚集,降低促炎因子释放,大大降低PCI术后并发症。

关 键 词:替罗非班  经皮冠状动脉介入治疗  急性心肌梗死  炎症

Impact analysis of Tirofiban to the anti-inflammatory and pro-inflammatory factors in patients with acute myocardial infarction after PCI
PAN Guozhou. Impact analysis of Tirofiban to the anti-inflammatory and pro-inflammatory factors in patients with acute myocardial infarction after PCI[J]. China Medical Herald, 2011, 8(29): 57-58,60
Authors:PAN Guozhou
Affiliation:PAN Guozhou Department of Cardiology,the People's Hospital of Baise City,Guangxi Zhuang Autonomous Region,Baise 533000,China
Abstract:Objective: To study the effect of Tirofiban to the anti-inflammatory and pro-inflammatory factors in patients with acute myocardial infarction(AMI) after PCI.Methods: 95 patients with AMI treated by percutaneous coronary intervention(PCI) in our hospital from October 2009 to December 2010 were selected and divided randomly into conventional treatment group(n=54) and Tirofiban group(n=41).The level of IL-6,IL-10,P-selectin and CRP of serum were measured.Results: The level of IL-6 in the conventional treatmen...
Keywords:Tirofiban  Percutaneous coronary intervention  Acute myocardial infarction  Inflammation  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号